4.3 Article

Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus

Related references

Note: Only part of the references are listed.
Article Immunology

Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway

Jing Wen et al.

JOURNAL OF AUTOIMMUNITY (2013)

Article Biochemistry & Molecular Biology

TWEAK as a target for therapy in systemic lupus erythematosus

Rui-Xue Leng et al.

MOLECULAR BIOLOGY REPORTS (2011)

Review Rheumatology

Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations

George K. Bertsias et al.

NATURE REVIEWS RHEUMATOLOGY (2010)

Article Cell Biology

TWEAK is expressed at the cell surface of monocytes during multiple sclerosis

Sophie Desplat-Jego et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2009)

Article Rheumatology

Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study

Noa Schwartz et al.

ARTHRITIS RESEARCH & THERAPY (2009)

Review Biotechnology & Applied Microbiology

The TWEAK - Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting

Jeffrey A. Winkles

NATURE REVIEWS DRUG DISCOVERY (2008)

Article Neurosciences

TWEAK and the central nervous system

Manuel Yepes

MOLECULAR NEUROBIOLOGY (2007)

Article Neurosciences

Tumor necrosis factor-like weak inducer of apoptosis-induced neurodegeneration

I Potrovita et al.

JOURNAL OF NEUROSCIENCE (2004)

Article Immunology

TWEAK is expressed by glial cells, induces astrocyte proliferation and increases EAE severity

S Desplat-Jégo et al.

JOURNAL OF NEUROIMMUNOLOGY (2002)